Schedule 13G ownership disclosure
APREA THERAPEUTICS INC
Common Stock, $0.001 par value per share · CUSIP: 03836J102
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Orin Hirschman
Shares: 651,747.00 · Class: 9.9%
- AIGH Capital Management LLC
Shares: 651,747.00 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-26-003971
- Form type
- SCHEDULE 13G/A
- Filer
- Aprea Therapeutics, Inc.
- CIK
- CIK 1781983
- Filed
- Jan 28, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership